In our study, the GeneFA scoring system with risk factors of age, serum fibrinogen levels, and CYP2C19 LOF alleles was established to predict the HRPR for CAD patients with clopidogrel treatment in our study. Here, CYP2C19 is linked to coronary artery disorder.